Diabetech - Diabetes Tech, Research, News Inside Medtronic‘s New Instinct CGM & What's Next
Dec 8, 2025
Laura Endres, Senior VP at Medtronic Diabetes, shares exciting insights about the new Instinct CGM. This 15-day, no-calibration sensor integrates seamlessly with the 780G insulin pump and highlights Medtronic's partnership with Abbott. Laura offers a live demo, showcasing its user-friendly applicator. She compares Instinct with Simplera, discusses future pump innovations, and emphasizes the importance of customer choice in sensor technology. Plus, get a glimpse of upcoming features like customizable alerts and global rollout plans!
AI Snips
Chapters
Transcript
Episode notes
Fast Launch Via Strategic Partnership
- Medtronic sped up Instinct's launch by combining its approved algorithm with Abbott's approved sensor technology.
- Laura Endres said the partnership and regulatory pathways let them deliver the product rapidly to customers.
Regulatory Shifts Speed Innovation
- FDA and industry standards are accelerating safe approvals for diabetes tech.
- Laura Endres noted these regulatory shifts helped bring products to market faster.
Why Abbott Was The Sensor Partner
- Abbott was chosen because of its small 15-day sensor, wide global user base, and advanced sensor tech.
- Laura Endres said Abbott's scale and form factor made it a logical partner for improving 780G.